Yahav Achim Ve Achayot - Provident Funds Management Company’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-25,330
| Closed | -$212K | – | 66 |
|
|
2022
Q4 | $212K | Hold |
25,330
| – | – | 0.2% | 56 |
|
|
2022
Q3 | $208K | Hold |
25,330
| – | – | 0.2% | 54 |
|
|
2022
Q2 | $206K | Hold |
25,330
| – | – | 0.18% | 56 |
|
|
2022
Q1 | $219K | Hold |
25,330
| – | – | 0.17% | 55 |
|
|
2021
Q4 | $251K | Hold |
25,330
| – | – | 0.18% | 53 |
|
|
2021
Q3 | $426K | Buy |
+25,330
| New | +$426K | 0.33% | 50 |
|